{
  "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
  "docSlug": "c241ac9edd2443452257949ce0a73d65",
  "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
  "authorId": "immix-biopharma",
  "authorName": "Immix Biopharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 61,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 12,
  "notes": "The slide uses a numbered list format to present key value propositions.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/3",
  "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
  "deckJsonHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920.json",
  "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.1,
        "x": 0.87,
        "y": 0.04
      },
      "kind": "image",
      "text": "IMMIX BIOPHARMA",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21ffe2d6-eab4-4878-aa3e-15304e3ebce8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.8,
        "w": 0.95,
        "x": 0.02,
        "y": 1
      },
      "kind": "list",
      "text": "1. NXC-201 - First CAR-T in AL Amyloidosis\n2. Addressing shortage of multiple myeloma CAR-Ts\n3. First CAR-T Overcoming Neurotoxicity\n4. NXC-201 n=72 patients 9 peer-reviewed publications\n5. IMX-110 - promising results in colorectal cancer with 30 patients dosed",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0e1a62aa-6468-4c3a-9d0a-956bcf100f90",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.02,
        "y": 0.05
      },
      "kind": "title",
      "text": "IMMIX Biopharma Investment Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a681d68-017f-4d0d-8d72-3b572c9cecef",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "2f8d1289-e754-4c4e-955d-8e78f1f5278c",
      "evidence": "The slide presents an executive summary of IMMIX Biopharma's investment highlights, including key points and achievements.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "66892045-fd78-45a3-a32d-13ceca6e95c6",
      "evidence": "Numbered list of key investment highlights",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 3,
      "from": 1,
      "beatId": "cfa0c1bd-b8ce-4ae0-b88d-4c0c279158ba",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Attention",
      "beatSlug": "aida-attention",
      "evidence": "The deck starts with a cover slide, disclaimer, and executive summary highlighting key points",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Hook",
      "parentBeatSlug": "hook"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}